IT
ITRM
Iterum Therapeutics plc
No data for this timeframe.
Vol
Analyst ConsensusSell (0%)
Reddit Sentiment50° Neutral
Recent Activity
May 13, 2026
earnings_calendar
ITRM Q1 2026 Earnings Scheduled — 2026-05-13
Analyst Ratings
0Strong Buy
0Buy
3Hold
1Sell
2Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Mar 30, 2026 | HC Wainwright & Co. | DOWNGRADE | Buy → Neutral |
| Aug 15, 2024 | HC Wainwright & Co. | MAINTAIN | Buy → Buy |
| Jun 21, 2024 | HC Wainwright & Co. | REITERATE | Buy → Buy |
| May 31, 2024 | HC Wainwright & Co. | REITERATE | Buy → Buy |
| May 14, 2024 | HC Wainwright & Co. | REITERATE | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Next FY | $-0.24 ▲ +22.6% | $-0.24 — $-0.24 | 67% YoY | 1 |
| Current FY | $-0.73 ▼ -10.6% | $-0.73 — $-0.73 | 42% YoY | 1 |
| Current Q | $-0.20 ▼ -37.9% | $-0.20 — $-0.20 | 20% YoY | 1 |
Reddit Sentiment
50°
Neutral
Bearish
Neutral
Bullish
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Sell (0% buy). Based on 6 analysts: 0 strong buy, 0 buy, 3 hold, 1 sell, 2 strong sell.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Next Q 2026-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY 2026-12-31 |
$-0.24 | $-0.24 | $-0.24 | 67.1% | +22.6% | — | $0.0B | 1150.0% | 1 |
| Current FY 2025-12-31 |
$-0.73 | $-0.73 | $-0.73 | 42.1% | -10.6% | — | $0.0B | 0.0% | 1 |
| Current Q 2025-12-31 |
$-0.20 | $-0.20 | $-0.20 | 20.0% | -37.9% | — | $0.0B | 0.0% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.200 | |
| 7d ago | $-0.145 | -0.055 |
| 30d ago | $-0.145 | -0.055 |
| 60d ago | $-0.145 | -0.055 |
| 90d ago | $-0.145 | -0.055 |
1 analyst firms have rated this stock: 1 upgrades, 1 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Mar 30, 2026 | HC Wainwright & Co. | DOWNGRADE | Buy | Neutral |
| Aug 15, 2024 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Jun 21, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| May 31, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| May 14, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Apr 30, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Apr 1, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Mar 6, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Feb 7, 2024 | HC Wainwright & Co. | UPGRADE | Neutral | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Apr 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Mar 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Feb 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Jan 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Dec 1, 2025 | 2 | 5 | 1 | 0 | 0 | 88% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
50°
Neutral
Bearish
Neutral
Bullish
2 mentions
0 bullish
0 bearish
2 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Mar 16, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
| Mar 16, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
Recent Reddit Threads
May 13, 2026
earnings_calendar
ITRM Q1 2026 Earnings Scheduled — 2026-05-13
May 11, 2026
earnings_calendar
ITRM Q1 2026 Earnings Scheduled — 2026-05-11
Apr 29, 2026
earnings_calendar
ITRM Q4 2025 Earnings After Market Close — 2026-04-29
Mar 31, 2026
short_volume
Short Volume: ITRM — 59.7% short (10.4M / 17.4M)
Short: 10,370,193 | Exempt: 1,362,237 | TRF Vol: 17,373,817 | Short Ratio: 59.7% | Off-exchange volume (dark pool + OTC)
Mar 27, 2026
other
Iterum Therapeutics Announces Filing of Winding Up Petition
<p>DUBLIN and CHICAGO, March 27, 2026 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (in Provisional Liquidation) (Nasdaq: ITRM) (the “Company” or “Ite
Mar 12, 2026
earnings_calendar
ITRM Q4 2025 Earnings After Market Close — 2026-03-12